The gamma delta T cell gambit inspires a small London biotech startup with big ideas
If you run through the whole gamut of cell therapies being worked on in cancer research these days, gamma delta T cells aren’t likely to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
